A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Abd El-Rehim, 2004, Expression of luminal and basal cytokeratins in human breast carcinoma, J. Pathol., 203, 661, 10.1002/path.1559

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100

Albertson, 2003, Chromosome aberrations in solid tumors, Nat. Genet., 34, 369, 10.1038/ng1215

Alimandi, 1995, Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas, Oncogene, 10, 1813

Beck, 2001, Gene array analysis of osteoblast differentiation, Cell Growth Differ., 12, 61

Carter, 2005, Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases, Proc. Natl. Acad. Sci. USA, 102, 11011, 10.1073/pnas.0504952102

Cattoretti, 1988, Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas, Br. J. Cancer, 57, 353, 10.1038/bjc.1988.81

Charafe-Jauffret, 2006, Gene expression profiling of breast cell lines identifies potential new basal markers, Oncogene, 25, 2273, 10.1038/sj.onc.1209254

Cheng, 2004, The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers, Nat. Med., 10, 1251, 10.1038/nm1125

Chin, 2006, Genomic and transcriptional aberrations linked to breast cancer pathophysiologies, Cancer Cell, 10, 529, 10.1016/j.ccr.2006.10.009

Chung, 2002, Molecular portraits and the family tree of cancer, Nat. Genet., 32, 533, 10.1038/ng1038

Dontu, 2003, In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells, Genes Dev., 17, 1253, 10.1101/gad.1061803

Dontu, 2003, Stem cells in normal breast development and breast cancer, Cell Prolif., 36, 59, 10.1046/j.1365-2184.36.s.1.6.x

Eisen, 1998, Cluster analysis and display of genome-wide expression patterns, Proc. Natl. Acad. Sci. USA, 95, 14863, 10.1073/pnas.95.25.14863

Ethier, 1993, Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media, Cancer Res., 53, 627

Feldman, 2003, Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression, Cancer Res., 63, 4626

Fridlyand, 2006, Breast tumor copy number aberration phenotypes and genomic instability, BMC Cancer, 6, 96, 10.1186/1471-2407-6-96

Gazdar, 1998, Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, Int. J. Cancer, 78, 766, 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L

Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Hodgson, 2001, Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas, Nat. Genet., 29, 459, 10.1038/ng771

Hyman, 2002, Impact of DNA amplification on gene expression patterns in breast cancer, Cancer Res., 62, 6240

Hynes, 2005, ERBB receptors and cancer: The complexity of targeted inhibitors, Nat. Rev. Cancer, 5, 341, 10.1038/nrc1609

Irizarry, 2003, Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, 4, 249, 10.1093/biostatistics/4.2.249

Jain, 2002, Fully automatic quantification of microarray image data, Genome Res., 12, 325, 10.1101/gr.210902

Jeffrey, 2005, Genomics-based prognosis and therapeutic prediction in breast cancer, J. Natl. Compr. Canc. Netw., 3, 291, 10.6004/jnccn.2005.0016

Jones, 2004, Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer, Cancer Res., 64, 3037, 10.1158/0008-5472.CAN-03-2028

Kallioniemi, 1994, Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors, Genes Chromosomes Cancer, 10, 231, 10.1002/gcc.2870100403

Korsching, 2002, Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis, Lab. Invest., 82, 1525, 10.1097/01.LAB.0000038508.86221.B3

Kuperwasser, 2004, Reconstruction of functionally normal and malignant human breast tissues in mice, Proc. Natl. Acad. Sci. USA, 101, 4966, 10.1073/pnas.0401064101

Lane, 2000, ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency, Mol. Cell. Biol., 20, 3210, 10.1128/MCB.20.9.3210-3223.2000

Larramendy, 2000, Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines, Cancer Genet. Cytogenet., 119, 132, 10.1016/S0165-4608(99)00226-5

Lim, 2000, Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system, Nat. Genet., 25, 209, 10.1038/76080

Loo, 2004, Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes, Cancer Res., 64, 8541, 10.1158/0008-5472.CAN-04-1992

Mahon, 2000, Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance, Blood, 96, 1070, 10.1182/blood.V96.3.1070

Nahta, 2004, P27(kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells, Cancer Res., 64, 3981, 10.1158/0008-5472.CAN-03-3900

Neve, 2000, Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells, Oncogene, 19, 1647, 10.1038/sj.onc.1203470

Neve, 2004, Genomic events in breast cancer progression, 383

Nielsen, 2004, Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clin. Cancer Res., 10, 5367, 10.1158/1078-0432.CCR-04-0220

Perou, 1999, Distinctive gene expression patterns in human mammary epithelial cells and breast cancers, Proc. Natl. Acad. Sci. USA, 96, 9212, 10.1073/pnas.96.16.9212

Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093

Pollack, 2002, Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors, Proc. Natl. Acad. Sci. USA, 99, 12963, 10.1073/pnas.162471999

Radisky, 2004, Cancer. Respect thy neighbor!, Science, 303, 775, 10.1126/science.1094412

Roylance, 1999, Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer, Cancer Res., 59, 1433

Saldanha, 2004, Java treeview—Extensible visualization of microarray data, Bioinformatics, 20, 3246, 10.1093/bioinformatics/bth349

Shadeo, 2006, Comprehensive copy number profiles of breast cancer cell model genomes, Breast Cancer Res., 8, R9, 10.1186/bcr1370

Simpson, 2004, Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue, J. Pathol., 202, 274, 10.1002/path.1530

Snijders, 2001, Assembly of microarrays for genome-wide measurement of DNA copy number, Nat. Genet., 29, 263, 10.1038/ng754

Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. USA, 98, 10869, 10.1073/pnas.191367098

Souchelnytskyi, 2002, Proteomics in studies of signal transduction in epithelial cells, J. Mammary Gland Biol. Neoplasia, 7, 359, 10.1023/A:1024029930563

Stingl, 1998, Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast, Differentiation, 63, 201, 10.1111/j.1432-0436.1998.00201.x

Tibshirani, 2002, Diagnosis of multiple cancer types by shrunken centroids of gene expression, Proc. Natl. Acad. Sci. USA, 99, 6567, 10.1073/pnas.082099299

Tirkkonen, 1998, Molecular cytogenetics of primary breast cancer by CGH, Genes Chromosomes Cancer, 21, 177, 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X

Tracy, 2004, Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255, Cancer Res., 64, 7241, 10.1158/0008-5472.CAN-04-1905

Vogel, 2001, First-line Herceptin monotherapy in metastatic breast cancer, Oncology, 61, 37, 10.1159/000055400

Vogel, 2005, Efficacy of trastuzumab, Cancer Res., 65, 2044, 10.1158/0008-5472.CAN-04-3943

Wouters, 2003, Graphical exploration of gene expression data: a comparative study of three multivariate methods, Biometrics, 59, 1131, 10.1111/j.0006-341X.2003.00130.x

Zhao, 2004, An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays, Cancer Res., 64, 3060, 10.1158/0008-5472.CAN-03-3308